Amniotic fluid insulin levels and fetal abdominal circumference at time of amniocentesis in pregnancies with diabetes

Diabetic Medicine

Volumn 20, Issue 5, 2003, Pages 349-354

  Schaefer Graf, Ute M ^a,b,d   Kjos, S L ^b,c   Buhling K J ^b   Henrich, W ^b   Brauer, M ^b   Heinze, T ^b   Dudenhausen, J W ^b   Vetter, K ^a  

^a VIVANTES KLINIKUM NEUKÖLLN   (Germany)

^b HUMBOLDT UNIVERSITY   (Germany)

^c UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^d CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

Amniotic fluid insulin; Diabetes; Fetal abdominal circumference; Macrosomia; Pregnancy

Indexed keywords

INSULIN;

ADULT; AMNIOCENTESIS; AMNION FLUID ANALYSIS; ARTICLE; ECHOGRAPHY; FEMALE; FETUS DISEASE; GESTATIONAL AGE; HUMAN; HYPERINSULINISM; MAJOR CLINICAL STUDY; NEWBORN MORBIDITY; PREGNANCY DIABETES MELLITUS; RECEIVER OPERATING CHARACTERISTIC; THIRD TRIMESTER PREGNANCY;

ADULT; AMNIOCENTESIS; AMNIOTIC FLUID; BODY WEIGHTS AND MEASURES; CROSS-SECTIONAL STUDIES; FEMALE; FETAL MACROSOMIA; GESTATIONAL AGE; GLUCOSE TOLERANCE TEST; HUMANS; HYPERINSULINISM; INSULIN; PREGNANCY; PREGNANCY IN DIABETICS; RETROSPECTIVE STUDIES;

EID: 0037854444     PISSN: 07423071     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1464-5491.2003.00946.x     Document Type: Article

References (26)

1. Coustan DR, Imarah J. Prophylactic insulin therapy treatment of gestational diabetes reduces the incidence of macrosomia, operative delivery and birth trauma. Am J Obstet Gynecol 1984; 150: 836-842.
2. Jovanovic-Peterson L, Bevier W, Peterson C. The Santa Barbara County Health Services Program: birth weight change concomitant with screening for and treatment of glucose-intolerance of pregnancy: a potential cost-effective intervention? Am J Perinatol 1997; 14: 221-228.
3. Langer O, Levy J, Brustmann L, Anyaegbunam A, Merkatz R, Divon M. Glycemic control in gestational diabetes mellitus - how tight is enough: small for gestational age versus large for gestational age. Am J Obstet Gynecol 1989; 161: 646-653.
4. Metzger BE, Freinkel N. Amniotic fluid insulin as a predictor of obesity. Arch Dis Child 1990; 65: 1050.
5. Pedersen J, Osler M. Hyperglycemia as the cause of characteristic features of the foetus and newborn in diabetic mothers. Dan Med Bull 1961; 8: 78.
6. Weiss PAM, Hofmann HMH. Monitoring pregnancy in diabetes: amniotic fluid. Diab Nutr Metab 1990; 3: 31-35.
7. Persson B, Heding LG. Fetal beta cell function in diabetic pregnancy. Am J Obstet Gynecol 1982; 144: 455-459.
8. Weiss PAM, Hofmann HM. Diagnosis and treatment of gestational diabetes according to amniotic fluid insulin levels. Arch Gynecol 1986; 239: 81-91.
9. Weiss PAM. Gestational diabetes: a survey and the Graz approach to diagnosis and therapy. In Weiss P, Coustan D eds. Gestational Diabetes. Vienna: Springer-Verlag, 1988: 1-55.
10. Buchanan TA, Kjos SL, Montoro MN, Wu P, Madrilejo NG, Gonzalez M et al. Use of fetal ultrasound to select metabolic therapy for pregnancies complicated by mild gestational diabetes. Diabetes Care 1994; 17: 275-283.
11. Buchanan TA, Kjos SL, Schaefer UM, Peters R, Xiang A, Byrne J et al. Utility of fetal measurements in the management of gestational diabetes. Diabetes Care 1998; 21: 99-106.
12. Kjos S, Schaefer-Graf UM, Sardesi S, Peters R, Buley A, Xiang A et al. A randomized controlled trial using glycemic plus fetal ultrasound parameters versus glycemic parameters to determine insulin therapy in gestational diabetes with fasting hyperglycemia. Diabetes Care 2001; 24: 1904-1910.
13. Landon MB, Mintz MC, Gabbe SG. Sonographic evaluation of fetal abdominal growth: predictor of large-for-gestational-age infant in pregnancies complicated by diabetes mellitus. Am J Obstet Gynecol 1989; 160: 115-121.
14. Bochner CJ, Medearis AL, Williams J, Castro L, Hobel CJ, Wade ME. Early third-trimester ultrasound screening in gestational diabetes to determine the risk of macrosomia and labor dystocia at term. Am J Obstet Gynecol 1987; 157: 703-708.
15. American College of Obstetricians and Gynecologists. Practice Bullettin: Gestational diabetes. Obstet Gynecol 2001; 98: 525-538.
16. Metzger BE, Coustan DR. Summary and Recommendations of the Four International Workshop-Conference on Gestational Diabetes. Diabetes Care 1998; 21: 161-167.
17. Hadden D. When and how to start insulin treatment in gestational diabetes: a UK perspective. Diabet Med 2001; 18: 960-964.
18. Deutsche Diabetes-Gesellschaft. Diagnostik und Therapie des Gestationsdiabetes. Richtlinien der Deutschen Diabetes-Gesellschaft (Diagnostic and therapy of GDM. Guidelines from the German Diabetes Association). Der Frauenarzt, 1993; 13-14.
19. Hadlock FP, Deter RL, Harrist RB, Park SK. Estimated fetal age: computer-assisted analysis of multiple fetal growth parameters. Radiology 1984; 1: 497-501.
20. Woltmann W, Dudenhausen JW. Insulin, C-Peptide und IGF 1 im Fruchtwasser stoffwechselgesunder Schwangeren (Insulin, C-peptide and IGF 1 in amniotic fluid of metabolic healthy women). Thesis, Free University, Berlin; 1994.
21. Weiss P. Lessons from the fetus. In Dornhorst A, Hadden D eds. Diabetes and Pregnancy. Chichester: Wiley, 1996: 221-240.
22. Fallucca F, Gargiulo P, Pachi A. Amniotic fluid insulin, C peptide concentrations, and fetal morbidity in infants of diabetic mothers. Am J Obstet Gynecol 1985; 153: 534-540.
23. Schaefer UM, Dupak J, Vogel M, Heinze T, Kjos SL, Buchanan TA et al. Hyperinsulinism, neonatal adiposity and placental immaturity in infants born to women with one abnormal glucose tolerance test value. J Perinatal Med 1998; 26: 27-36.
24. Schwartz L. Hyperinsulinemia and macrosomia. N Engl J Med 1990; 323: 340-342.
25. Kainer F, Weiss PAM, Hüttner U, Haas J. Ultrasound growth parameters in relation to levels of amniotic fluid insulin in women with diabetes type I. Early Hum Dev 1997; 49: 113-121.
26. Burkhart W, Holzgreve W, Dame WR, Schneider HPG. Antenatal assessment of fetal outcome in pregnant diabetics. J Perinat Med 1986; 14: 293-297.